- Featured Product
- KD/KO Validated
CEBPG Polyclonal antibody
CEBPG Polyclonal Antibody for IF, WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human, mouse, rat
Applications
WB, IHC, IF, ELISA
Conjugate
Unconjugated
Cat no : 12997-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | mouse heart tissue, MCF-7 cells |
Positive IF detected in | MCF-7 cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:200-1:1000 |
Immunofluorescence (IF) | IF : 1:1000-1:4000 |
Sample-dependent, check data in validation data gallery |
Published Applications
KD/KO | See 2 publications below |
WB | See 2 publications below |
IHC | See 3 publications below |
Product Information
12997-1-AP targets CEBPG in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
Tested Reactivity | human, mouse, rat |
Cited Reactivity | human, mouse |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | CEBPG fusion protein Ag3663 |
Full Name | CCAAT/enhancer binding protein (C/EBP), gamma |
Calculated molecular weight | 150 aa, 16 kDa |
Observed molecular weight | 45-50 kDa |
GenBank accession number | BC013128 |
Gene symbol | CEBPG |
Gene ID (NCBI) | 1054 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
Product Specific Protocols | |
---|---|
WB protocol for CEBPG antibody 12997-1-AP | Download protocol |
IF protocol for CEBPG antibody 12997-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Neuron Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells.
| ||
Am J Cancer Res CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling.
| ||
J Transl Med CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer |